Targeting mTOR for the treatment of B cell malignancies.
about
A CRISPR/Cas9 Functional Screen Identifies Rare Tumor Suppressors.The combination of digoxin and GSK2606414 exerts synergistic anticancer activity against leukemia in vitro and in vivo.Control of B lymphocyte development and functions by the mTOR signaling pathways.Mechanistic target of rapamycin modulation: an emerging therapeutic approach in a wide variety of disease processes.mTORC1 Inhibition Induces Resistance to Methotrexate and 6-Mercaptopurine in Ph+ and Ph-like B-ALL.Rictor/mTORC2 deficiency enhances keratinocyte stress tolerance via mitohormesis.Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update
P2860
Q37508613-3ECC62D3-E8E9-4A53-ABFE-B787591DAB00Q38620165-3E890D18-FBF9-4675-9152-4115770A3225Q38674507-0D076A45-E931-43FD-9C70-25871E2F17BCQ42700873-9CC84B91-4E09-458A-9178-5D5FE1C159CBQ44274584-B148DBFB-A877-4851-A987-0A3693F4D99EQ46416340-CB680439-4165-4768-8B41-4E93F25021BFQ56378380-B31865F3-3DD0-4546-B481-4FECE42636A4
P2860
Targeting mTOR for the treatment of B cell malignancies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Targeting mTOR for the treatment of B cell malignancies.
@en
type
label
Targeting mTOR for the treatment of B cell malignancies.
@en
prefLabel
Targeting mTOR for the treatment of B cell malignancies.
@en
P2093
P2860
P356
P1476
Targeting mTOR for the treatment of B cell malignancies.
@en
P2093
David A Fruman
Jong-Hoon Scott Lee
Thanh-Trang Vo
P2860
P304
P356
10.1111/BCP.12888
P407
P577
2016-01-25T00:00:00Z